Skip to Main Content
Newsroom
BD & Partnering
Get in Touch
LinkedIn
X Mobile
Editas Medicine Linkedin
Research and Pipeline
CRISPR Gene Editing
For Patients
Who We Are
Join Our Team
Investors
Newsroom
BD & Partnering
Get in Touch
LinkedIn
X Mobile
Purchasing Policy Terms and Conditions
+
-
Editas Newsroom
Mar
9
Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates
Feb
23
Editas Medicine to Participate in Upcoming Investor Conferences
Nov
10
Editas Medicine Announces Third Quarter 2025 Results and Business Updates